Evoltra 1 mg/ml concentrate for solution for infusion

DRUG3 trials

Sponsors

Vaestra Goetalandsregionen, Prinses Maxima Centrum voor Kinderoncologie B.V., Medical University Of Vienna

Conditions

AMLAcute Myeoloid LeukemiaUrothelial carcinoma

Phase 1

A Phase Ib study of Vyxeos® (liposomal daunorubicin and cytarabine) in combination with Clofarabine in children with relapsed/refractory AML

RecruitingCTIS2023-508050-26-00

Prinses Maxima Centrum voor Kinderoncologie B.V.AML

Start: 2025-07-17Target: 25Updated: 2025-10-21

Clofarabine Therapy in Patients with Locally Advanced or Metastatic Urothelial Carcinoma: a Phase 1/2 Dose-Escalation Study

RecruitingCTIS2024-516586-37-00

Medical University Of ViennaUrothelial carcinoma

Start: 2023-10-24Target: 50Updated: 2024-10-14

Phase 3

A Randomized, Multi-Center Phase III Trial comparing two conditioning regimens (CloFluBu and BuCyMel) in children with Acute Myeloid Leukemia undergoing allogeneic stem cell transplantation.

RecruitingCTIS2023-505512-37-00

Vaestra GoetalandsregionenAcute Myeoloid Leukemia

Start: 2022-06-07Target: 105Updated: 2025-11-06